Understanding lipoprotein(a) in cardiovascular disease
October 27, 2021
Epidemiological and mendelian randomization studies have demonstrated lipoprotein(a) to be an independent risk factor for myocardial infarction and stroke. Lipoprotein(a) consists of a specific apolipoprotein(a) that is highly heritable and bound to LDL-C particles. Recent research has increased the understanding of Lipoprotein(a) in disease and new therapies are emerging. In this webinar speakers will review the current knowledge on lipoprotein(a) from human genetics to atherogenic mechanisms and emerging drug treatment targeting lipoprotein (a).